Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis
Clinical trial NCT01999192 · TERMINATED
Trial details
- NCT number
- NCT01999192
- Sponsor
- Biotest
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-07-01
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.